Search research articles
Contact Us
Filters
Showing results (191-200 of 250) with videos related to
Page
of 25
Sort By:
Molecular and Cellular Biochemistry
|
February 22, 2015
Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways
Yinhang Yu, Fuliang Bai, Yaonan Liu, et al.
Nature Medicine
|
November 18, 2014
The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis
Guo-Xiao Wang, Xu-Yun Zhao, Zhuo-Xian Meng, et al.
Translational Oncology
|
July 16, 2017
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon
Jiayi Yu, Xiaowen Wu, Huan Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2021
Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma
Xieqiao Yan, Xinan Sheng, Zhihong Chi, et al.
Cancer Medicine
|
November 12, 2024
Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China
Siming Li, Yanxia Shi, Haiying Dong, et al.
Journal of Cancer Research and Clinical Oncology
|
July 20, 2023
A nomogram incorporating Ki67 to predict survival of acral melanoma
Yu Du, Caili Li, Lili Mao, et al.
Oncology Research
|
August 5, 2018
Efficacy Evaluation of Imatinib for the Treatment of Melanoma: Evidence From a Retrospective Study
Xiaoting Wei, Lili Mao, Zhihong Chi, et al.
Journal of Translational Medicine
|
December 6, 2017
Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy
Huan Yu, Meng Ma, Junya Yan, et al.
Urologic Oncology
|
July 14, 2020
Clinicopathological characteristics, prognosis, and chemosensitivity in patients with metastatic upper tract urothelial carcinoma
Xu Li, Siming Li, Zhihong Chi, et al.
The Oncologist
|
August 20, 2024
Predominance of hyperprogression in mucosal melanoma during anti-PD-1 monotherapy treatment
Li Zhou, Min Cao, Haibin Zhu, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 250) with videos related to
Sort By:
Page
of 25
Molecular and Cellular Biochemistry
|
February 22, 2015
Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways
Yinhang Yu, Fuliang Bai, Yaonan Liu, et al.
Nature Medicine
|
November 18, 2014
The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis
Guo-Xiao Wang, Xu-Yun Zhao, Zhuo-Xian Meng, et al.
Translational Oncology
|
July 16, 2017
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon
Jiayi Yu, Xiaowen Wu, Huan Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2021
Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma
Xieqiao Yan, Xinan Sheng, Zhihong Chi, et al.
Cancer Medicine
|
November 12, 2024
Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China
Siming Li, Yanxia Shi, Haiying Dong, et al.
Journal of Cancer Research and Clinical Oncology
|
July 20, 2023
A nomogram incorporating Ki67 to predict survival of acral melanoma
Yu Du, Caili Li, Lili Mao, et al.
Oncology Research
|
August 5, 2018
Efficacy Evaluation of Imatinib for the Treatment of Melanoma: Evidence From a Retrospective Study
Xiaoting Wei, Lili Mao, Zhihong Chi, et al.
Journal of Translational Medicine
|
December 6, 2017
Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy
Huan Yu, Meng Ma, Junya Yan, et al.
Urologic Oncology
|
July 14, 2020
Clinicopathological characteristics, prognosis, and chemosensitivity in patients with metastatic upper tract urothelial carcinoma
Xu Li, Siming Li, Zhihong Chi, et al.
The Oncologist
|
August 20, 2024
Predominance of hyperprogression in mucosal melanoma during anti-PD-1 monotherapy treatment
Li Zhou, Min Cao, Haibin Zhu, et al.
Page
of 25